Concomitant Splenic Tuberculosis and Epstein-Barr Virus-Related T-Cell Leukemia/Lymphoma in a 28-Year-Old Pregnant Woman in South Sudan.

Publication date: Apr 15, 2025

This case report presents a rare instance of concomitant splenic tuberculosis (TB), Epstein-Barr virus (EBV)-related T-cell leukemia/lymphoma, and malaria in a 28-year-old pregnant woman at a McE9decins Sans FronticE8res-supported hospital in South Sudan. The patient was admitted with splenomegaly, anorexia, weakness, and transfusion-refractory anemia. She tested positive for malaria and was treated appropriately. Because of ongoing consumptive anemia, cachexia, and weakness severely impacting her quality of life, the patient underwent splenectomy. A diagnosis of TB was ultimately confirmed post-splenectomy through histopathological analysis and molecular testing. Gross findings from the pathologic analysis of a splenic sample revealed miliary deposits, necrotizing granulomas, and atypical lymphocytic infiltrates consistent with TB and EBV-associated leukemia/lymphoma. Despite temporary improvement post-operatively and the initiation of TB therapy, the patient discontinued treatment and was lost to follow-up, likely resulting in mortality. This report presents an unusual combination of concomitant pathologies that underscore the diagnostic challenges and complexity of managing overlapping infectious and hematological disorders in resource-limited settings.

Concepts Keywords
Leukemia Barr
Molecular Cell
Old Concomitant
Pregnant Epstein
Therapy Leukemia
Lymphoma
Old
Patient
Pregnant
Related
Splenic
Tuberculosis
Virus
Year

Semantics

Type Source Name
disease MESH Splenic Tuberculosis
disease MESH T-Cell Leukemia
disease MESH Lymphoma
disease MESH malaria
pathway KEGG Malaria
disease MESH splenomegaly
disease MESH anorexia
disease MESH refractory anemia
disease MESH anemia
disease IDO quality
disease MESH granulomas
disease MESH leukemia
disease MESH lost to follow-up

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *

Concomitant Splenic Tuberculosis and Epstein-Barr Virus-Related T-Cell Leukemia/Lymphoma in a 28-Year-Old Pregnant Woman in South Sudan.

Publication date: Apr 15, 2025

This case report presents a rare instance of concomitant splenic tuberculosis (TB), Epstein-Barr virus (EBV)-related T-cell leukemia/lymphoma, and malaria in a 28-year-old pregnant woman at a McE9decins Sans FronticE8res-supported hospital in South Sudan. The patient was admitted with splenomegaly, anorexia, weakness, and transfusion-refractory anemia. She tested positive for malaria and was treated appropriately. Because of ongoing consumptive anemia, cachexia, and weakness severely impacting her quality of life, the patient underwent splenectomy. A diagnosis of TB was ultimately confirmed post-splenectomy through histopathological analysis and molecular testing. Gross findings from the pathologic analysis of a splenic sample revealed miliary deposits, necrotizing granulomas, and atypical lymphocytic infiltrates consistent with TB and EBV-associated leukemia/lymphoma. Despite temporary improvement post-operatively and the initiation of TB therapy, the patient discontinued treatment and was lost to follow-up, likely resulting in mortality. This report presents an unusual combination of concomitant pathologies that underscore the diagnostic challenges and complexity of managing overlapping infectious and hematological disorders in resource-limited settings.

Concepts Keywords
Leukemia Barr
Molecular Cell
Old Concomitant
Pregnant Epstein
Therapy Leukemia
Lymphoma
Old
Patient
Pregnant
Related
Splenic
Tuberculosis
Virus
Year

Semantics

Type Source Name
disease MESH Splenic Tuberculosis
disease MESH T-Cell Leukemia
disease MESH Lymphoma
disease MESH malaria
pathway KEGG Malaria
disease MESH splenomegaly
disease MESH anorexia
disease MESH refractory anemia
disease MESH anemia
disease IDO quality
disease MESH granulomas
disease MESH leukemia
disease MESH lost to follow-up

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *